EMCDDA news

The EMCDDA has published today its latest update on Drug-related infectious diseases in Europe for the period to February 2019. The publication provides an overview of the most recent infectious disease surveillance data, outbreak investigations and prevention and control measures among people who inject drugs (PWID) in Europe. The information presented is collected through the EMCDDA’s drug-related infectious diseases (DRID) network. Below are some of the findings ‘At a glance’. 28.06.2019 

This content was published in the Best pratice portal update briefing on 27.06.2019 26.06.2019 

Cannabis products have become increasingly diverse in Europe and close monitoring of their potency and potential health effects is essential. These are among the conclusions of a new report published today by the EU drugs agency (EMCDDA) ahead of International day against drug abuse and illicit trafficking (26 June) (1). 25.06.2019 

An external evaluation of the EMCDDA, new products and services, and support to policy and practice in the fields of health and security are among the features presented in the latest General Report of Activities published today by the agency. The report, covering key achievements and governance in 2018, presents the implementation of the EMCDDA work programme activities over the 12-month period. 14.06.2019 

A new EMCDDA Rapid Communication, published on 29 May, presents the results of an innovative project to gather information on the substances used by people who inject drugs, by chemically analysing the residual content of used syringes. 05.06.2019